Results 121 to 130 of about 8,812 (165)

GLIMMER: an interim subgroup analysis from an ongoing prospective study evaluating hyperspectral imaging for MGMT promoter methylation in gliomas. [PDF]

J Neurooncol
Wach J, Weber F, Wende T, Vychopen M, Barrantes-Freer A, Pfahl A, Köhler H, Güresir E.   +7 more
europepmc   +1 more source

Conditional survival in glioblastoma: The evolution of prognostic factors over time. [PDF]

Int J Cancer
Mueller T, Vasella F, Velz J, Voglis S, Akeret K, Padevit L, Schubert M, Weller J, Brüningk S, Rushing E, Sarnthein J, Gramatzki D, Häni L, Raabe A, Zeitlberger AM, Bozinov O, Le Rhun E, Weller M, Regli L, Neidert MC.   +19 more
europepmc   +1 more source

Glioblastoma survival in rural America: a 10-year experience from a quaternary care center. [PDF]

J Neurooncol
Pack E, Cifarelli CP, Bhatia S, Lewis J, Brandmeir N, Gleckman A, Han PC, Wages NA, Dotson TS, Denney MW, Wen S, Armistead M, Norouzi S, Aulakh S.   +13 more
europepmc   +1 more source

Knockdown of 5-methylcytosine RNA methyltransferase NOP2/sun RNA methyltransferase 5 in hepatocellular carcinoma cells affects their biological functions. [PDF]

World J Gastrointest Surg
Liu N, Liu J, Wang YL, Zhu L, Zhu CW.
europepmc   +1 more source

Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer. [PDF]

Cancer Epidemiol Biomarkers Prev
Gurjao C, Cazaubiel J, Tan C, Reardon B, Hofree M, Ugai T, Meyerhardt JA, Nowak JA, Giovannucci E, Townsend JP, Ogino S, Giannakis M.   +11 more
europepmc   +1 more source

Methylations in dilated cardiomyopathy and heart failure. [PDF]

Front Cardiovasc Med
Qin C, Qin Y, Zhou S.
europepmc   +1 more source

Bacteria sense virus-induced genome degradation via methylated mononucleotides

Osterman I, Hurieve B, Moses S, Falkovich AH, Itkin M, Malitsky S, Yirmiya E, Sorek R.   +7 more
europepmc   +1 more source

Profile and diagnostic value of N6-methyladenosine-related mRNA regulators in colorectal adenoma and colorectal cancer. [PDF]

BMC Gastroenterol
Wang W, Zhang X, Wang M, Wang L, Qian S, Cheng W, Xu F, Ding S, Zhu Y, Jin G, Yang W, Hu A, Zhao Q.   +12 more
europepmc   +1 more source

Optimal qMSP cutoff value for MGMT promoter methylation in glioblastoma and its validation for clinical significance. [PDF]

BMC Cancer
Huseyinoglu Z, Uysal E, Inan MA, Demirci T, Gokay G, Aras FK, Erdamar S, Ozduman K, Pamir MN, Danyeli AE.   +9 more
europepmc   +1 more source

EGFR pathway alterations correlate with rapid early progression in glioblastoma. [PDF]

J Neurooncol
Samimi K, Saini AS, Cullison K, Herr J, Mellon EA.   +4 more
europepmc   +1 more source